Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Twin Hospitality Group Inc. Announces Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
-
Party City Locations Restocked with New Merchandise as Store Closing Sales Enter Final Weeks
-
Tiziana Life Sciences Announces Long Covid Study to Complete in Second Quarter
-
GDEV Provides Clarification In Respect Of Previously Announced Special Cash Dividend
-
Bango launches world’s first all-in-one Super Bundling technology
-
ProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription Drugs
-
ZJK Industrial Expands Market Presence, Strengthens Key Collaborations and Responds to Supply-Chain Shifts
-
ASP Isotopes Inc. to Present at Canaccord Genuity Sustainability Summit on Wednesday, February 26, 2025
-
New APR Energy Deploys 100MW+ of Mobile Gas Turbines for U.S. Based AI Hyperscaler
-
ZenaTech’s ZenaDrone Finalizes its Third Generation Design and “Production Model” of the ZenaDrone 1000 for US Defense and Commercial Markets
-
ContextLogic Announces Up to $150 Million Strategic Investment by BC Partners
-
American Oncology Network Launches Cloud-Based Laboratory Information System to Streamline Pathology Reporting for Oncologists
-
Portillo’s Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results
-
Avalyn to Participate in TD Cowen 45th Annual Health Care Conference
-
TipMeFast, Inc. Announces Change of Name to Lucent, Inc.
-
Celularity Receives FDA Tissue Reference Group Recommendation Letters for its Natalin and Acelagraft™ Wound Care Products
-
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Interface Recognized as One of the Best Places to Work in the US for the Second Year in a Row
-
Ackroo Announces Voting Results From Annual and Special Meeting of Shareholders
-
Oncotelic Accesses Rapid IND Development Platform through Partnership with Medicilon
-
Heartflow Unveils Bold New Vision for Management of Coronary Artery Disease
-
BioRestorative to Provide a Positive FDA Update on Clinical Pipeline
-
Matthews International Corporation Announces Expiration of HSR Waiting Period
-
REPEAT: Rocket Doctor Approved as In-Network Provider for New York Medicaid, Expands Partnership with EngageWell to Enhance Care
-
KickBallz® to Leverage Nogin’s Enterprise-Class Ecommerce Technology and End-to-End Services to Launch New D2C Sales Channel
-
Alector to Participate in Upcoming Healthcare Conferences
-
Loadsmart Launches ShipperGuide Marketplace for On-Demand Truckload Shipping
-
Merus to Present at Upcoming Investor Conferences
-
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results
-
Kestra Medical Technologies, Ltd. Appoints Neil Bhalodkar as Vice President of Investor Relations
-
Indaptus Therapeutics’ Chief Scientific Officer Dr. Michael Newman to Present at the 10th Annual Innate Killer Summit
-
Color Star Joins WBC for an Unforgettable Night in Boxing History
-
Regula Recognized as a Representative Vendor in the Gartner Market Guide for KYC Platforms for Banking
-
DailyMail+ Subscription Service Launches in U.S. and Canada
-
LiveOne (Nasdaq: LVO) and PodcastOne (Nasdaq: PODC) Promote Ryan Carhart to Chief Financial Officer
-
PureSky Energy Announces Full Term Conversion of Largest-to-Date Solar Portfolio
-
MediWound Announces Phase III CIDS Publication on NexoBrid® for Pediatric Burn Care
-
Viemed Healthcare Announces Year End 2024 Earnings Conference Call Details
-
Amarin Receives National Reimbursement for VAZKEPA® in Austria
-
Abacus Life to Announce Fourth Quarter 2024 Financial Results on Thursday, March 27, 2025
-
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in March
-
New KnowBe4 Report Reveals the Hidden Power of Information Sharing in Shaping an Organization’s Security Culture
-
Information Regarding Šiaulių Bankas 2024 Results Announcement Time
-
Municipality Finance will redeem early notes issued under its MTN programme
-
Evaxion extends phase 2 trial with personalized cancer vaccine EVX-01 to further enhance clinical data package
-
Camposol Holding PLC reports Preliminary Fourth Quarter and Full Year 2024 Results.
-
Fixing of coupon rates - Nykredit Realkredit A/S
-
Western Resources Corp. Provides Bi-weekly MCTO Status Update
-
Fujifilm Awarded Exclusive Defense Logistics Agency (DLA) Contract for its Surgical C-Arm Systems
-
American Tungsten Corp. Responds to Potential U.S. Tariffs Against Canada and Mexico

